Please login to the form below

Not currently logged in
Email:
Password:

Repatha

This page shows the latest Repatha news and features for those working in and with pharma, biotech and healthcare.

TMC’s full data for inclisiran impresses at ESC

TMC’s full data for inclisiran impresses at ESC

Other PCKS9 targeting drugs, including Amgen’s  Repatha and Sanofi/Regeneron’s  Praluent, directly target the  PCKS9 protein.

Latest news

More from news
Approximately 32 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Astellas: Ten years young Astellas: Ten years young

    Repatha from Amgen was the first in the class to be approved in Japan in January, although it will likely only be months before Sanofi's rival Praluent will join it

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics